Balance Sheets (Million Baht) | Total Assets | Total Liabilities | Total Shareholders’ Equity | Income Statements (Million Baht) | Revenue from Hospital Operations | Total Operating Income | Net Profit (Excluding Non-Recurring Items) | Net Profit | Liquidity Ratio | Current Ratio (x) | Quick Ratio (x) | Operating Cash Flow Ratio (x) | Average Collection Period (Days) | Average Inventory Period (Days) | Average Payable Period (Days) | Profitability Ratio (%) 1/ | Gross Profit Margin 1/ | EBIT to Net Sale | Operating Cash Flow to EBIT | Net Profit Margin | Return on Equity | Efficiency Ratio 1/ | Return on Assets (%) | Return on Fixed Assets (%) | Asset Turnover (x) | Financial Policy Ratio | Total Liabilities to Equity (x) | Interest Coverage (x) 2/ | Commitment Coverage on Cash Basis (x) | Dividend Payout (%) 3/ |
---|---|---|---|---|---|
2017 | 2016 | 2015 | 2014 | 2013 | |
Total Assets | 122,627 | 107,015 | 102,335 | 93,370 | 76,549 |
Total Liabilities | 56,756 | 48,710 | 47,338 | 45,653 | 33,864 |
Total Shareholders’ Equity | 65,871 | 58,305 | 54,997 | 47,717 | 42,685 |
Revenue from Hospital Operations | 69,123 | 65,237 | 60,240 | 54,341 | 49,170 |
Total Operating Income | 72,772 | 68,844 | 63,633 | 56,607 | 51,158 |
Net Profit (Excluding Non-Recurring Items) | 8,021 | 8,220 | 7,812 | 7,109 | 6,113 |
Net Profit | 10,216 | 8,386 | 8,021 | 7,394 | 6,261 |
Current Ratio (x) | 1.1 | 0.7 | 0.9 | 0.9 | 0.9 |
Quick Ratio (x) | 0.9 | 0.6 | 0.8 | 0.8 | 0.8 |
Operating Cash Flow Ratio (x) | 0.7 | 0.8 | 0.9 | 0.8 | 0.7 |
Average Collection Period (Days) | 34.0 | 35.4 | 37.8 | 37.3 | 35.4 |
Average Inventory Period (Days) | 12.2 | 11.1 | 10.5 | 10.0 | 9.3 |
Average Payable Period (Days) | 34.3 | 37.1 | 40.8 | 41.3 | 41.5 |
Gross Profit Margin 1/ | 33.3 | 33.4 | 34.5 | 34.9 | 34.8 |
EBIT to Net Sale | 16.4 | 16.7 | 17.8 | 17.9 | 17.2 |
Operating Cash Flow to EBIT | 92.7 | 109.5 | 115.3 | 103.7 | 97.8 |
Net Profit Margin | 14.0 | 12.2 | 12.6 | 12.6 | 11.9 |
Return on Equity | 17.2 | 15.5 | 16.4 | 17.2 | 16.2 |
Return on Assets (%) | 8.9 | 8.0 | 8.2 | 8.7 | 8.6 |
Return on Fixed Assets (%) | 24.0 | 24.1 | 24.8 | 25.1 | 25.8 |
Asset Turnover (x) | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
Total Liabilities to Equity (x) | 0.9 | 0.8 | 0.9 | 1.0 | 0.8 |
Interest Coverage (x) 2/ | 10.1 | 16.7 | 12.5 | 13.0 | 11.4 |
Commitment Coverage on Cash Basis (x) | 0.4 | 0.5 | 0.5 | 0.3 | 0.4 |
Dividend Payout (%) 3/ | 54.64/ | 53.6 | 50.2 | 48.2 | 49.4 |
1/ Gross profit margin = Gross profit/revenue from hospital operations and revenue from goods and food
2/ Interest coverage = EBITDA/interest expenses
3/ Dividend payout ratio = Dividend per share/earnings per share (including non-recurring items)
4/ Board of Directors had resolution on 28 February 2018 to propose for dividend payment of Baht 0.36 per share. However, the Company paid interim dividend at the rate of Baht 0.13 per share from the Board of Directors resolution on 30 August 2017. Therefore, the Company shall pay an additional dividend at Baht 0.23 per share.
Remark: - EPS has been adjusted to reflect the change in par value from THB 1.00/share to THB 0.10/share since April 2014
2012* | 2013 | 2014* | 2015* | 2016* | 2017 | 2018 | |
Q1 | 11,083 | 12,438 | 14,023 | 15,748 | 17,297 | 17,395 | 20,029 |
Q2 | 10,813 | 12,018 | 13,191 | 14,853 | 15,678 | 17,144 | - |
Q3 | 12,032 | 13,485 | 14,388 | 16,203 | 18,203 | 19,498 | - |
Q4 | 12,066 | 13,218 | 15,005 | 16,829 | 17,666 | 18,734 | - |
* restated financial statement
Remark:- Operating income is calculated from hopsital revenue + revenue from sales of goods and food + other income
2012* | 2013 | 2014* | 2015* | 2016* | 2017 | 2018 | |
Q1 | 2,746 | 3,076 | 3,464 | 3,871 | 4,077 | 3,790 | 4,933 |
Q2 | 2,410 | 2,274 | 2,711 | 2,949 | 3,058 | 3,366 | - |
Q3 | 2,894 | 2,802 | 3,299 | 3,497 | 3,926 | 4,422 | - |
Q4 | 2,687 | 2,725 | 3,299 | 3,903 | 3,665 | 3,898 | - |
* restated financial statement
2012* | 2013 | 2014* | 2015* | 2016* | 2017 | 2018 | |
Q1 | 1,394 | 1,948 | 2,075 | 2,289 | 2,406 | 1,974 | 2,919 |
Q2 | 1,280 | 1,347 | 1,501 | 1,491 | 1,669 | 3,791 | - |
Q3 | 1,986 | 1,549 | 1,928 | 2,087 | 2,334 | 2,417 | - |
Q4 | 1,389 | 1,417 | 1,890 | 2,153 | 1,977 | 2,035 | - |
* restated financial statement
Remark: excluding non-recurring items